- Home
- MTEN vs ANEB Comparison
MTEN vs ANEB Comparison
Compare MTEN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- ANEB
- Stock Information
- Founded
- MTEN 2015
- ANEB 2020
- Country
- MTEN China
- ANEB United States
- Employees
- MTEN N/A
- ANEB N/A
- Industry
- MTEN Building Products
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- MTEN Industrials
- ANEB Health Care
- Exchange
- MTEN Nasdaq
- ANEB Nasdaq
- Market Cap
- MTEN 29.3M
- ANEB 111.8M
- IPO Year
- MTEN 2024
- ANEB 2021
- Fundamental
- Price
- MTEN $4.50
- ANEB $2.57
- Analyst Decision
- MTEN
- ANEB Buy
- Analyst Count
- MTEN 0
- ANEB 2
- Target Price
- MTEN N/A
- ANEB $8.00
- AVG Volume (30 Days)
- MTEN 102.7K
- ANEB 41.5K
- Earning Date
- MTEN 10-01-2025
- ANEB 11-12-2025
- Dividend Yield
- MTEN N/A
- ANEB N/A
- EPS Growth
- MTEN N/A
- ANEB N/A
- EPS
- MTEN N/A
- ANEB N/A
- Revenue
- MTEN $10,735,337.00
- ANEB N/A
- Revenue This Year
- MTEN N/A
- ANEB N/A
- Revenue Next Year
- MTEN N/A
- ANEB N/A
- P/E Ratio
- MTEN N/A
- ANEB N/A
- Revenue Growth
- MTEN 16.63
- ANEB N/A
- 52 Week Low
- MTEN $3.20
- ANEB $0.80
- 52 Week High
- MTEN $26.03
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- MTEN 30.36
- ANEB 57.21
- Support Level
- MTEN $3.35
- ANEB $2.30
- Resistance Level
- MTEN $5.86
- ANEB $2.74
- Average True Range (ATR)
- MTEN 0.96
- ANEB 0.14
- MACD
- MTEN 0.05
- ANEB 0.03
- Stochastic Oscillator
- MTEN 36.28
- ANEB 66.98
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.